Serum chemokine (C-X-C Motif) ligand 10 levels are elevated in patients with graves' disease in long-term remission

Thyroid

Volumn 20, Issue 3, 2010, Pages 341-342

  Sakai, Hiroyuki ^a   Togawa, Yoshiko ^a   Fukuda, Gen ^a   Ito, Rokuro ^a   Miwa, Takashi ^a   Odawara, Masato ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; REMISSION; THYROIDITIS; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION;

AGED; CHEMOKINE CXCL10; DISEASE-FREE SURVIVAL; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED;

EID: 77649305152     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0179     Document Type: Letter

References (6)

1. Zlotnik A, Yoshie O 2000 Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.
2. Kimura H, Caturegli P 2007 Chemokine orchestration of autoimmune thyroiditis. Thyroid 17:1005-1011.
3. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M 2006 Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin Endocrinol (Oxf) 64:189-195.
4. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M 2002 Expression of IP-10=CXCL10 and MIG=CXCL9 in the thyroid and increased levels of IP-10=CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 161:195-206.
5. Inukai Y, Momobayashi A, Sugawara N, Aso Y 2007 Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease. Eur J Endocrinol 156:623-630.
6. Domberg J, Liu C, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC, Schott M 2008 Circulating chemokines in patients with autoimmune thyroid diseases. Horm Metab Res 40:416-421.